[Triple blind comparative study with IBH-194].
D000813:Anilides / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002214:Capsules; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D009288:Naproxen / Q000627:therapeutic use*; D009539:Nicotinic Acids / Q000627:therapeutic use*; D010919:Placebos; D012216:Rheumatic Diseases / Q000188:drug therapy*
D000813:Anilides; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002214:Capsules; D009539:Nicotinic Acids; D010919:Placebos; D009288:Naproxen
Estudio comparativo a triple ciego conIBH-194.